Assorted Patent Opposition Papers and Royalty Correspondence

Assorted correspondence and papers relating to patents connected to anti-TNF patent and royalty cases involving the Kennedy Institute and Kennedy Trust. Includes papers relating to patent anti-TNF antibodies/TNF receptor and methotrexate in the treatment of autoimmune disease, multiple administrations of anti-TNF antibody, methods of preventing or treating thrombosis with Tumor Necrosis Factor antagonists, suppression of Tumor Necrosis Factor alpha and endothelial and Anti-tumor necrosis factor alpha antibodies and anti-interleukin-12 antibodies in the treatment of arthritis.

Includes declarations, patent opposition summaries, Kennedy Institute response to opposition, correspondence, general patent application papers, royalty, and licensing agreement copies.

Please see SA/KET/A/4 for further papers relating to the above-mentioned patents.

1997-2008

1 file (in 3 parts)

This item is closed and cannot be accessed. Please see our Access Policy for more details. Closed until 1 January 2039.